Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.15% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Communication Services | 10.55% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2451
Imperial Petroleum
IMPP
$252M
| $1.07M | ﹤0.01% |
223,696
+142,096
| +174% | +$500K |
2023 Q4
7 quarters
|
|
2452
AMCON Distributing
DIT
$64.8M
| $1.07M | ﹤0.01% |
14,048
-15
| -0.1% | -$1.15K |
2013 Q2
49 quarters
|
|
2453
XPEL
XPEL
$1.21B
| $1.06M | ﹤0.01% |
+32,014
| New | +$1.14M |
2025 Q3
0 quarters
|
|
2454
RGC Resources
RGCO
$234M
| $1.06M | ﹤0.01% |
47,033
+400
| +0.9% | +$8.77K |
2018 Q3
28 quarters
|
|
2455
iShares Latin America 40 ETF
ILF
$4.17B
| $1.05M | ﹤0.01% |
36,500
+6,800
| +23% | +$181K |
2025 Q2
1 quarter
|
|
2456
Zevia
ZVIA
$85.8M
| $1.05M | ﹤0.01% |
386,826
+82,700
| +27% | +$238K |
2023 Q3
8 quarters
|
|
2457
Moog Inc Class B
MOG.B
$11.7B
| $1.05M | ﹤0.01% |
5,100
| – | – |
2016 Q2
37 quarters
|
|
|
MDV
2458
DELISTED
Modiv Industrial
MDV
| $1.05M | ﹤0.01% |
71,749
+749
| +1% | +$11.1K |
2023 Q4
7 quarters
|
|
2459
DELISTED
AstroNova
ALOT
| $1.05M | ﹤0.01% |
102,542
+700
| +0.7% | +$7.74K |
2013 Q2
49 quarters
|
|
2460
Rapport Therapeutics
RAPP
$1.46B
| $1.05M | ﹤0.01% |
35,300
+19,700
| +126% | +$351K |
2025 Q2
1 quarter
|
|
2461
Lyell Immunopharma
LYEL
$207M
| $1.04M | ﹤0.01% |
63,990
-3,200
| -5% | -$36.5K |
2023 Q4
7 quarters
|
|
2462
First Bank
FRBA
$438M
| $1.04M | ﹤0.01% |
63,788
-5,068
| -7% | -$81.2K |
2016 Q4
35 quarters
|
|
2463
Citizens
CIA
$177M
| $1.04M | ﹤0.01% |
197,594
-28,400
| -13% | -$133K |
2018 Q3
28 quarters
|
|
2464
HBT Financial
HBT
$1.29B
| $1.04M | ﹤0.01% |
41,100
+18,900
| +85% | +$485K |
2024 Q1
6 quarters
|
|
2465
Unilever
UL
$135B
| $1.03M | ﹤0.01% |
+15,502
| New | +$1.07M |
2025 Q3
0 quarters
|
|
2466
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$2.85B
| $1.03M | ﹤0.01% |
+23,200
| New | +$1.02M |
2025 Q3
0 quarters
|
|
2467
Aldeyra Therapeutics
ALDX
$55.2M
| $1.03M | ﹤0.01% |
197,300
+84,500
| +75% | +$441K |
2022 Q2
13 quarters
|
|
2468
MainStreet Bancshares
MNSB
$178M
| $1.03M | ﹤0.01% |
49,388
+21,388
| +76% | +$450K |
2020 Q4
19 quarters
|
|
2469
Sabre
SABR
$767M
| $1.03M | ﹤0.01% |
562,149
+325,400
| +137% | +$767K |
2025 Q2
1 quarter
|
|
2470
Lincoln National
LNC
$7.82B
| $1.03M | ﹤0.01% |
+25,474
| New | +$985K |
2025 Q3
0 quarters
|
|
2471
Vanguard Financials ETF
VFH
$13.1B
| $1.02M | ﹤0.01% |
7,800
-400
| -5% | -$51.8K |
2025 Q2
1 quarter
|
|
2472
Trio-Tech International Common Stock
TRT
$57.6M
| $1.02M | ﹤0.01% |
344,026
-3,400
| -1% | -$9.29K |
2013 Q2
49 quarters
|
|
2473
GrafTech
EAF
$226M
| $1.01M | ﹤0.01% |
78,931
+38,421
| +95% | +$445K |
2025 Q1
2 quarters
|
|
2474
International Flavors & Fragrances
IFF
$21.6B
| $1.01M | ﹤0.01% |
16,400
-471,427
| -97% | -$32.4M |
2023 Q4
7 quarters
|
|
2475
HUB Group
HUBG
$1.63B
| $1M | ﹤0.01% |
29,172
-32,300
| -53% | -$1.15M |
2025 Q2
1 quarter
|
|
Similar funds
Renaissance Technologies's Q3 2025 Portfolio in Review
As of Q3 2025, Renaissance Technologies held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class C worth $419M.
- Renaissance Technologies's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Renaissance Technologies's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Renaissance Technologies fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Renaissance Technologies opened 515 new positions and closed 581 in Q3 2025.
- Renaissance Technologies's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.